Cargando…

Chemically Homogenous Compounds with Antagonistic Properties at All α(1)-Adrenoceptor Subtypes but not β(1)-Adrenoceptor Attenuate Adrenaline-Induced Arrhythmia in Rats

Studies proved that among all α(1)-adrenoceptors, cardiac myocytes functionally express only α(1A)- and α(1B)-subtype. Scientists indicated that α(1A)-subtype blockade might be beneficial in restoring normal heart rhythm. Therefore, we aimed to determine the role of α(1)-adrenoceptors subtypes (i.e....

Descripción completa

Detalles Bibliográficos
Autores principales:	Pytka, Karolina, Lustyk, Klaudia, Żmudzka, Elżbieta, Kotańska, Magdalena, Siwek, Agata, Zygmunt, Małgorzata, Dziedziczak, Agnieszka, Śniecikowska, Joanna, Olczyk, Adrian, Gałuszka, Adam, Śmieja, Jarosław, Waszkielewicz, Anna M., Marona, Henryk, Filipek, Barbara, Sapa, Jacek, Mogilski, Szczepan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971072/ https://www.ncbi.nlm.nih.gov/pubmed/27536240 http://dx.doi.org/10.3389/fphar.2016.00229

Ejemplares similares

The antidepressant- and anxiolytic-like activities of new xanthone derivative with piperazine moiety in behavioral tests in mice
por: Pytka, Karolina, et al.
Publicado: (2016)

MH-76, a Novel Non-Quinazoline α(1)-Adrenoceptor Antagonist, but Not Prazosin Reduces Inflammation and Improves Insulin Signaling in Adipose Tissue of Fructose-Fed Rats
por: Kubacka, Monika, et al.
Publicado: (2021)

Manifestations of Liver Impairment and the Effects of MH-76, a Non-Quinazoline α1-Adrenoceptor Antagonist, and Prazosin on Liver Tissue in Fructose-Induced Metabolic Syndrome
por: Kubacka, Monika, et al.
Publicado: (2023)

HBK-17, a 5-HT(1A) Receptor Ligand With Anxiolytic-Like Activity, Preferentially Activates ß-Arrestin Signaling
por: Pytka, Karolina, et al.
Publicado: (2018)

HBK-10, A Compound with α(1)-Adrenolytic Properties, Showed Antiarrhythmic and Hypotensive Effects in Rats
por: Lustyk, Klaudia, et al.
Publicado: (2022)

The Antiarrhythmic Activity of Novel Pyrrolidin-2-one Derivative S-75 in Adrenaline-Induced Arrhythmia
por: Lustyk, Klaudia, et al.
Publicado: (2021)

Novel Arylpiperazine Derivatives of Salicylamide with α(1)-Adrenolytic Properties Showed Antiarrhythmic and Hypotensive Properties in Rats
por: Żmudzka, Elżbieta, et al.
Publicado: (2022)

Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT(1A) and 5-HT(7) Antagonists in Animal Models
por: Pytka, Karolina, et al.
Publicado: (2015)

The Antiarrhythmic and Hypotensive Effects of S-61 and S-73, the Pyrrolidin-2-one Derivatives with α(1)-Adrenolytic Properties
por: Lustyk, Klaudia, et al.
Publicado: (2022)

Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice
por: Żmudzka, Elżbieta, et al.
Publicado: (2023)

Adrenaline-activated structure of the β(2)-adrenoceptor stabilized by an engineered nanobody
por: Ring, Aaron M., et al.
Publicado: (2013)

Synthesis and Evaluation of the Antidepressant-like Properties of HBK-10, a Novel 2-Methoxyphenylpiperazine Derivative Targeting the 5-HT(1A) and D(2) Receptors
por: Sałaciak, Kinga, et al.
Publicado: (2021)

A Comparison of the Anorectic Effect and Safety of the Alpha(2)-Adrenoceptor Ligands Guanfacine and Yohimbine in Rats with Diet-Induced Obesity
por: Dudek, Magdalena, et al.
Publicado: (2015)

Novel Multimodal Salicylamide Derivative with Antidepressant-like, Anxiolytic-like, Antipsychotic-like, and Anti-Amnesic Activity in Mice
por: Żmudzka, Elżbieta, et al.
Publicado: (2023)

β(1) Adrenoceptor antagonistic effects of the supposedly selective β(2) adrenoceptor antagonist ICI 118,551 on the positive inotropic effect of adrenaline in murine hearts
por: Pecha, Simon, et al.
Publicado: (2015)

β-Adrenoceptor subtypes and cAMP role in adrenaline- and noradrenaline-induced relaxation in the rat thoracic aorta
por: Shiina, Shunsuke, et al.
Publicado: (2018)

Idalopirdine, a selective 5-HT(6) receptor antagonist, reduces food intake and body weight in a model of excessive eating
por: Kotańska, Magdalena, et al.
Publicado: (2018)

Metabolic and cardiovascular benefits and risks of 4-hydroxy guanabenz hydrochloride: α(2)-adrenoceptor and trace amine-associated receptor 1 ligand
por: Kotańska, Magdalena, et al.
Publicado: (2023)

The Role of Adrenoceptors in the Retina
por: Ruan, Yue, et al.
Publicado: (2020)

Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents
por: Żmudzka, Elżbieta, et al.
Publicado: (2022)

Bioresearch of New 1H-pyrrolo[3,4-c]pyridine-1,3(2H)-diones
por: Szkatuła, Dominika, et al.
Publicado: (2020)

HBK-15, a Multimodal Compound, Showed an Anxiolytic-Like Effect in Rats
por: Lustyk, Klaudia, et al.
Publicado: (2022)

Relationships of Adrenoceptor Polymorphisms with Obesity
por: Masuo, Kazuko, et al.
Publicado: (2011)

Adrenal adrenoceptors in heart failure
por: de Lucia, Claudio, et al.
Publicado: (2014)

The Role of Adrenoceptors in Bronchial Asthma
por: Patel, K. R.
Publicado: (1979)

A Full Pharmacological Analysis of the Three Turkey β-Adrenoceptors and Comparison with the Human β-Adrenoceptors
por: Baker, Jillian G.
Publicado: (2010)

β-Adrenoceptor-mediated Relaxation of Urinary Bladder Muscle in β(2)-Adrenoceptor Knockout Mice
por: Propping, Stefan, et al.
Publicado: (2016)

Participation of hepatic α/β-adrenoceptors and AT(1) receptors in glucose release and portal hypertensive response induced by adrenaline or angiotensin II
por: de Araújo, L.J.T., et al.
Publicado: (2018)

The signaling and selectivity of α‐adrenoceptor agonists for the human α2A, α2B and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
por: Proudman, Richard G. W., et al.
Publicado: (2022)

Adrenoceptors: ligand-activated molecular dynamics
por: Matijssen, B, et al.
Publicado: (2008)

Beta-Adrenoceptor Blocking Drugs and the Elderly
por: Wilkins, M. R., et al.
Publicado: (1984)

Uses of Beta-Adrenoceptor Blocking Drugs
por: Prichard, B. N. C., et al.
Publicado: (1976)

The presence of β(2)-adrenoceptors sensitizes α(2A)-adrenoceptors to desensitization after chronic epinephrine treatment
por: Bawa-Khalfe, Tasneem, et al.
Publicado: (2007)

The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants and antipsychotics for the human α2A, α2B, and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
por: Proudman, Richard G.W., et al.
Publicado: (2022)

Metabolic and Cardiovascular Benefits and Risks of EMD386088—A 5-HT(6) Receptor Partial Agonist and Dopamine Transporter Inhibitor
por: Kotańska, Magdalena, et al.
Publicado: (2017)

The selectivity of α‐adrenoceptor agonists for the human α1A, α1B, and α1D‐adrenoceptors
por: Proudman, Richard G. W., et al.
Publicado: (2021)

β-Adrenoceptors and synaptic plasticity in the perirhinal cortex
por: Laing, M., et al.
Publicado: (2014)

β-Adrenoceptors Trigger Melatonin Synthesis in Phagocytes
por: Pires-Lapa, Marco A., et al.
Publicado: (2018)

Slow Release Beta Adrenoceptor Blocking Drugs
por: Harron, D. W. G., et al.
Publicado: (1983)

Celiprolol: A Unique Selective Adrenoceptor Modulator
por: Nawarskas, James J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_76qvsoetrumlipog42ogmlj9hv